Daehwajeayak Acquires Patent Rights for Syrup and Powder Formulation Technologies
[Asia Economy Reporter Ji Yeon-jin] Daehwa Pharmaceutical announced on the 4th that it has obtained a patent for an oral pharmaceutical composition in the form of a syrup or powder formulation containing water-soluble active pharmaceutical ingredients.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
This patent relates to a technology that formulates zanamivir inhalation into a syrup form to increase ease of administration, combining the advantages of syrup form with the convenience of storage and distribution while preventing moisture changes in the powder formulation.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
